---
schema_version: "secwatch.filing_event.v1"
accession: "0001625101-22-000010"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2022-03-21T23:59:59+00:00"
generated_at: "2026-06-26T21:23:57.927613+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences EVP & GM of Dermatology Ed Ebbers resigns; position eliminated

## Summary
- Ed Ebbers resigned as EVP & GM of Dermatology effective March 18, 2022; role eliminated in streamlining effort.
- Severance includes six months' base salary in 12 semi-monthly installments, plus $28,318 in lieu of 2022 cash bonus.
- Unvested equity awards accelerating over 12 months from separation date; COBRA health benefits continued.
- Company expects to enter a consulting arrangement with Ebbers for a smooth transition.
- Resignation not related to any disagreement over operations, policies, or practices.

## SEC filing metadata
- accession: 0001625101-22-000010
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2022-03-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/0001625101-22-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/plse-20220318x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625101-22-000010
- JSON: https://secwatch.observer/filing/0001625101-22-000010.json
- Plain text: https://secwatch.observer/filing/0001625101-22-000010.txt

## Key facts
- Executive change
  Ed Ebbers resigned as Executive Vice President and General Manager of Dermatology at PULSE BIOSCIENCES, INC..
  - Action: resigned
  - Role: Executive Vice President and General Manager of Dermatology
  source text: On March 18, 2022, the Company and Mr. Ed Ebbers, Executive Vice President and General Manager of Dermatology, agreed that he would resign from the Company, effective as of March 18, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/0001625101-22-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.